Cargando…

Development and evaluation of a teleoncology system for breast cancer during the COVID-19 pandemic

Background: The present study describes the steps of developing a hybrid teleoncology system to provide treatment plans for breast cancer patients. Materials & methods: This research was conducted in four stages, including developing a proposal for experts, identifying and analyzing system requi...

Descripción completa

Detalles Bibliográficos
Autores principales: Khodaveisi, Taleb, Sadoughi, Farahnaz, Novin, Kambiz, Hosseiniravandi, Mohammad, Dehnad, Afsaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842715/
https://www.ncbi.nlm.nih.gov/pubmed/35129376
http://dx.doi.org/10.2217/fon-2021-0822
_version_ 1784651106835496960
author Khodaveisi, Taleb
Sadoughi, Farahnaz
Novin, Kambiz
Hosseiniravandi, Mohammad
Dehnad, Afsaneh
author_facet Khodaveisi, Taleb
Sadoughi, Farahnaz
Novin, Kambiz
Hosseiniravandi, Mohammad
Dehnad, Afsaneh
author_sort Khodaveisi, Taleb
collection PubMed
description Background: The present study describes the steps of developing a hybrid teleoncology system to provide treatment plans for breast cancer patients. Materials & methods: This research was conducted in four stages, including developing a proposal for experts, identifying and analyzing system requirements, designing a prototype and implementing and evaluating the final version of the hybrid teleoncology system. Results: The results of the usability evaluation showed that the users evaluated the system at a good level and, in practice, the implemented system was perceived to be useful by specialists in providing treatment plans for cancer patients. Conclusion: The hybrid teleoncology system is a practical alternative to traditional methods for providing treatment plans to breast cancer patients.
format Online
Article
Text
id pubmed-8842715
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-88427152022-02-15 Development and evaluation of a teleoncology system for breast cancer during the COVID-19 pandemic Khodaveisi, Taleb Sadoughi, Farahnaz Novin, Kambiz Hosseiniravandi, Mohammad Dehnad, Afsaneh Future Oncol Research Article Background: The present study describes the steps of developing a hybrid teleoncology system to provide treatment plans for breast cancer patients. Materials & methods: This research was conducted in four stages, including developing a proposal for experts, identifying and analyzing system requirements, designing a prototype and implementing and evaluating the final version of the hybrid teleoncology system. Results: The results of the usability evaluation showed that the users evaluated the system at a good level and, in practice, the implemented system was perceived to be useful by specialists in providing treatment plans for cancer patients. Conclusion: The hybrid teleoncology system is a practical alternative to traditional methods for providing treatment plans to breast cancer patients. Future Medicine Ltd 2022-02-07 2022-01 /pmc/articles/PMC8842715/ /pubmed/35129376 http://dx.doi.org/10.2217/fon-2021-0822 Text en © 2022 Future Medicine Ltd https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Research Article
Khodaveisi, Taleb
Sadoughi, Farahnaz
Novin, Kambiz
Hosseiniravandi, Mohammad
Dehnad, Afsaneh
Development and evaluation of a teleoncology system for breast cancer during the COVID-19 pandemic
title Development and evaluation of a teleoncology system for breast cancer during the COVID-19 pandemic
title_full Development and evaluation of a teleoncology system for breast cancer during the COVID-19 pandemic
title_fullStr Development and evaluation of a teleoncology system for breast cancer during the COVID-19 pandemic
title_full_unstemmed Development and evaluation of a teleoncology system for breast cancer during the COVID-19 pandemic
title_short Development and evaluation of a teleoncology system for breast cancer during the COVID-19 pandemic
title_sort development and evaluation of a teleoncology system for breast cancer during the covid-19 pandemic
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842715/
https://www.ncbi.nlm.nih.gov/pubmed/35129376
http://dx.doi.org/10.2217/fon-2021-0822
work_keys_str_mv AT khodaveisitaleb developmentandevaluationofateleoncologysystemforbreastcancerduringthecovid19pandemic
AT sadoughifarahnaz developmentandevaluationofateleoncologysystemforbreastcancerduringthecovid19pandemic
AT novinkambiz developmentandevaluationofateleoncologysystemforbreastcancerduringthecovid19pandemic
AT hosseiniravandimohammad developmentandevaluationofateleoncologysystemforbreastcancerduringthecovid19pandemic
AT dehnadafsaneh developmentandevaluationofateleoncologysystemforbreastcancerduringthecovid19pandemic